Phase I trial of LBY135, a monoclonal antibody agonist to DR5, alone and in combination with capecitabine in advanced solid tumors

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 3538
Main Authors:	Sharma, S., de Vries, E. G., Infante, J. R., Oldenhuis, C., Chiang, L., Bilic, S., Goldbrunner, M., Scott, J. W., Burris, H. A.
Format:	Journal Article
Language:	English
Published:	20-05-2008
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!